embelin and paclitaxel

embelin has been researched along with paclitaxel in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1
Gao, X; Huang, Y; Li, J; Li, S; Lu, J; Rohan, LC; Stolz, DB; Sun, M; Venkataramanan, R; Zhao, W1
Gao, X; Huang, Y; Li, J; Li, S; Lu, J; Marquez, RT; Meng, X; Venkataramanan, R; Wang, Z; Zhao, W1

Other Studies

3 other study(ies) available for embelin and paclitaxel

ArticleYear
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012
PEG-derivatized embelin as a dual functional carrier for the delivery of paclitaxel.
    Bioconjugate chemistry, 2012, Jul-18, Volume: 23, Issue:7

    Topics: Animals; Antineoplastic Agents; Benzoquinones; Cell Proliferation; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Drug Screening Assays, Antitumor; Humans; Mice; Micelles; Molecular Structure; Paclitaxel; Particle Size; Polyethylene Glycols; Solubility; Structure-Activity Relationship; Surface Properties; Tumor Cells, Cultured

2012
PEG-derivatized embelin as a nanomicellar carrier for delivery of paclitaxel to breast and prostate cancers.
    Biomaterials, 2013, Volume: 34, Issue:5

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzoquinones; Breast Neoplasms; Cell Line, Tumor; Female; Male; Mice; Mice, Inbred BALB C; Micelles; Nanocapsules; Paclitaxel; Polyethylene Glycols; Prostatic Neoplasms; Treatment Outcome

2013